Faculty of Medicine Siriraj Hospital, Mahidol University is the oldest and largest medical school and oldest of any kind of university faculty in Thailand. The faculty is now part of Mahidol University.

During the past decade, Siriraj Hospital conducted 223 clinical trials. In the 10-year time frame, 223 clinical trials started and 56 clinical trials were completed, i.e. on average, 25.1% percent of trials that started reached the finish line to date. In the past 5 years, 99 clinical trials started and 33 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siriraj Hospital" #1 sponsor was "Mahidol University" with 163 trials, followed by "Siriraj Hospital" with 18 trials sponsored, "Janssen Research & Development, LLC" with 15 trials sponsored, "Gilead Sciences" with 10 trials sponsored and "Hoffmann-La Roche" with 10 trials sponsored. Other sponsors include 130 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siriraj Hospital" #1 collaborator was "Siriraj Hospital" with 8 trials as a collaborator, "Meddoc" with 4 trials as a collaborator, "Norwegian University of Life Sciences" with 4 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials as a collaborator and "CardioVascular Research Foundation, Korea" with 3 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Siriraj Hospital" are "HIV Infections" (12 trials), "Septic Shock" (7 trials), "Hepatitis B, Chronic" (6 trials), "HIV" (5 trials) and "Stroke" (5 trials). Many other conditions were trialed in "Siriraj Hospital" in a lesser frequency.

Most popular intervention types in "Siriraj Hospital" are "Drug" (205 trials), "Other" (52 trials), "Procedure" (27 trials), "Device" (23 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "BP-C1" (4 trials), "Normal saline" (4 trials), "placebo" (4 trials) and "ATV" (3 trials). Other intervention names were less common.

The vast majority of trials in "Siriraj Hospital" are 305 trials for "All" genders, 38 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 88 active trials in "Siriraj Hospital". 1 are not yet recruiting, 63 are recruiting, 23 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 184 completed trials in Siriraj Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Siriraj Hospital, 15 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 99 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 49 trials, and there were also 72 trials that are defined as “Not Applicable".